$TFFP TFF Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TFF Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TFF Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in TFF Pharmaceuticals, Inc. for free.
IRS Number: 824344737
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TFFP
Company Address: 2600 VIA FORTUNA, SUITE 360 AUSTIN 78746
Phone number: 737-802-1979
TFF Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | TFFP | TFF Pharmaceutical ... | Lung Therapeutics, Inc. | 10% Owner | Sell | S | 14.00 | 715,000 | 10,010,000 | 2,235,000 | 3 M to 2.2 M (-24.24 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 5.00 | 5,250 | 26,250 | 102,423 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Option Exercise | M | 2.50 | 14,756 | 36,890 | 107,673 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Sell | S | 16.85 | 20,006 | 337,101 | 15,722 | 35.7 K to 15.7 K (-56.00 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 5.00 | 5,250 | 26,250 | 35,728 | 30.5 K to 35.7 K (+17.23 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | ROCAMBOLI STEPHEN | Director | Buy | M | 2.50 | 14,756 | 36,890 | 30,478 | 15.7 K to 30.5 K (+93.86 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 50,000 | 125,000 | 944,227 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 17.04 | 50,000 | 852,000 | 10,000 | 60 K to 10 K (-83.33 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 50,000 | 125,000 | 60,000 | 10 K to 60 K (+500.00 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Option Exercise | M | 2.50 | 5,000 | 12,500 | 277,883 | |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Sell | S | 17.05 | 5,000 | 85,250 | 1,000 | 6 K to 1,000 (-83.33 %) |
| Mar 17 2021 | TFFP | TFF Pharmaceutical ... | COLEMAN KIRK ALLEN | CFO, Secretary and ... | Buy | M | 2.50 | 5,000 | 12,500 | 6,000 | 1,000 to 6 K (+500.00 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Option Exercise | M | 2.50 | 40,000 | 100,000 | 994,227 | |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Sell | S | 16.82 | 40,000 | 672,800 | 10,000 | 50 K to 10 K (-80.00 %) |
| Feb 18 2021 | TFFP | TFF Pharmaceutical ... | Mattes Glenn R. | President and CEO | Buy | M | 2.50 | 40,000 | 100,000 | 50,000 | 10 K to 50 K (+400.00 %) |